About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalSan Diego & Southern California
Clinical Trials (21)
View allTotal Trials
21
As Lead Sponsor
17
As Collaborator
4
Total Enrollment
1,532
By Phase
PHASE2: 12PHASE2/PHASE3: 1PHASE1: 5PHASE1/PHASE2: 2
By Status
COMPLETED: 17RECRUITING: 1ACTIVE_NOT_RECRUITING: 1TERMINATED: 1AVAILABLE: 1
Clinical Trials Pipeline20 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05464784Lead Sponsor
MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia
PHASE2Recruiting
40 participants
Started: Aug 22, 2022 · Completed: Dec 31, 2026
NCT04429555Lead Sponsor
Efficacy, Safety, Tolerability, and Biomarkers of Ibudilast (MN-166) in Patients Hospitalized With COVID-19 at Risk for ARDS
PHASE2Completed
34 participants
Started: Jan 11, 2021 · Completed: Aug 7, 2024
NCT04057898Lead Sponsor
Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS
PHASE2/PHASE3Active, not recruiting
234 participants
Started: May 28, 2020 · Completed: Dec 31, 2026
NCT04054206Lead Sponsor
Relative Bioavailability of MN-166 (Ibudilast) in Extended Release Tablet vs. Intermediate-release Capsule in Healthy Volunteers
PHASE1Completed
12 participants
Started: Jun 24, 2019 · Completed: May 31, 2020
NCT03782415Lead Sponsor
Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma
PHASE1/PHASE2Completed
64 participants
Started: Dec 29, 2018 · Completed: Aug 7, 2023
Locations (1)
Headquarters
La Jolla, CA, United States
Map
Loading map...